For research use only. Not for therapeutic Use.
Dirithromycin-d3(Cat No.:R016921) is a deuterated variant of Dirithromycin, designed for precise pharmacokinetic and metabolic studies in pharmaceutical research. With three deuterium atoms replacing hydrogen, this isotopically labeled compound enhances the accuracy of mass spectrometric analysis. It retains the antimicrobial efficacy of its parent compound, making it ideal for investigating drug behavior, absorption, and degradation patterns. Dirithromycin-d3 serves as a crucial tool for researchers aiming to optimize antibiotic therapies and understand resistance mechanisms, ensuring more effective clinical outcomes in antimicrobial treatments.
Catalog Number | R016921 |
CAS Number | NA |
Synonyms | [9S(R)]-9-Deoxo-11-deoxy-9,11-[imino[2-(2-methoxyethoxy)ethylidene]oxy]erythromycin-d3; ASE 136-d3; Antibiotic AS-E 136-d3; Dirythromycin-d3; Dynabac-d3; KT 237216-d3; LY 237216-d3; Noriclan-d3; Nortron-d3; Valodin-d3; |
Molecular Formula | C₄₇H₇₅D₃N₂O₁₄ |
Purity | ≥95% |
Storage | Store at +4C |
IUPAC Name | (1R,2R,3R,6R,7S,8S,9R,10R,12R,15R,17S)-3-ethyl-2,10-dihydroxy-7-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-[methyl(trideuteriomethyl)amino]oxan-2-yl]oxy-15-(2-methoxyethoxymethyl)-2,6,8,10,12,17-hexamethyl-4,16-dioxa-14-azabicyclo[11.3.1]heptadecan-5-one |
InChI | InChI=1S/C42H78N2O14/c1-15-29-42(10,49)37-24(4)32(43-30(56-37)21-52-17-16-50-13)22(2)19-40(8,48)36(58-39-33(45)28(44(11)12)18-23(3)53-39)25(5)34(26(6)38(47)55-29)57-31-20-41(9,51-14)35(46)27(7)54-31/h22-37,39,43,45-46,48-49H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,30-,31+,32?,33-,34+,35+,36-,37-,39+,40-,41-,42-/m1/s1/i11D3 |
InChIKey | WLOHNSSYAXHWNR-CEWUKNABSA-N |
SMILES | [2H]C([2H])([2H])N(C)[C@H]1C[C@H](O[C@H]([C@@H]1O)O[C@@H]2[C@H]([C@@H]([C@H](C(=O)O[C@@H]([C@@]([C@H]3[C@H](C([C@@H](C[C@@]2(C)O)C)N[C@H](O3)COCCOC)C)(C)O)CC)C)O[C@H]4C[C@@]([C@H]([C@@H](O4)C)O)(C)OC)C)C |